At Chacruna: Microdosing Controversy: Where Do You Stand?

Ingmar Gorman

Just a year ago when Katherine MacLean, Andrew Tatarsky, and I met to discuss the outline for our next workshop for the Psychedelic Education and Continuing Care Program, microdosing was a topic we would have rather avoided. “There just isn’t enough data out there, what can we say?” As professionals, we wanted to rely on published findings on the topic, a core tenant we adhere to when teaching others about psychedelics... continue reading.